ArticleJournal of cardiothoracic surgery2026
Global research trends and prognostic risk factors for ST-segment elevation myocardial infarction: a bibliometric analysis from 2003 to 2025.
Article in Journal of cardiothoracic surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundPrognostic risk factors exert a critical influence on outcomes in patients with ST-segment elevation myocardial infarction (STEMI). However, global research trends and the primary determinants of research hotspots remain to be fully elucidated.
methodsA bibliometric analysis was conducted using CiteSpace and VOSviewer on 416 English-language publications retrieved from the Web of Science Core Collection database spanning 2003 to 2025. The analysis evaluated publication trends, contributions by country and institution, author productivity, journal impact, keyword co-occurrence, and citation networks.
resultsThe annual number of publications demonstrated a steady increase, particularly post-2016, reflecting a surge in scientific interest. China emerged as the leading contributor in terms of publication output. Author analysis identified 115 core authors, with Gierlotka, Marek and Polonski, Lech being the most prolific. The collaborative author network revealed five major research clusters. BMC Cardiovascular Disorders was identified as the primary source journal, while Circulation exhibited the highest citation impact. Keyword co-occurrence and burst detection analysis highlighted evolving research focuses, including risk stratification, primary angioplasty, inflammation, heart failure, and biomarker-based prognosis. Key risk factors influencing STEMI prognosis included advanced age, diabetes, hypertension, obesity, acute kidney injury, cardiogenic shock, and cardiac arrest. Current research trends focus on biomarkers and scoring systems; specifically, there is a trend toward investigating target biomarkers such as CXCL16 and miR-146a, while scoring systems still require tools specifically tailored for STEMI.
conclusionThe field of STEMI prognosis research is progressively evolving. Current research hotspots are concentrated on risk factors affecting STEMI prognosis, the investigation of targeted biomarkers, and the development of risk stratificat.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.